Advertisement

Histiocytic Diseases

Published:October 18, 2022DOI:https://doi.org/10.1016/j.cvsm.2022.07.010

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Moore P.F.
        A review of histiocytic diseases of dogs and cats.
        Vet Pathol. 2014; 51: 167-184
        • Cline M.J.
        Histiocytes and histiocytosis.
        Blood. 1994; 84: 2840-2853
        • Favara B.E.
        • Feller A.C.
        • Pauli M.
        • et al.
        Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.
        Med Pediatr Oncol. 1997; 29: 157-166
        • Merad M.
        • Ginhoux F.
        • Collin M.
        Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells.
        Nat Rev Immunol. 2008; 8: 935-947
        • D'Agostino P.M.
        • Gottfried-Blackmore A.
        • Anandasabapathy N.
        • et al.
        Brain dendritic cells: biology and pathology.
        Acta Neuropathol. 2012; 124: 599-614
        • Shortman K.
        • Naik S.H.
        Steady-state and inflammatory dendritic-cell development.
        Nat Rev Immunol. 2007; 7: 19-30
        • Looringh van Beeck F.A.
        • Zajonc D.M.
        • Moore P.F.
        • et al.
        Two canine CD1a proteins are differentially expressed in skin.
        Immunogenetics. 2008; 60: 315-324
        • Moore P.
        • Affolter V.
        • Olivry T.
        • et al.
        The use of immunological reagents in defining the pathogenesis of canine skin diseases involving proliferation of leukocytes.
        in: Kwotchka K. Willemse T. von Tscharner C. Advances in Veterinary Dermatology. Butterworth Heinmann, 1998: 77-94
        • Moore P.F.
        • Schrenzel M.D.
        • Affolter V.K.
        • et al.
        Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific beta(2)-integrin molecules.
        Am J Pathol. 1996; 148: 1699-1708
        • Saint-Andre Marchal I.
        • Dezutter-Dambuyant C.
        • Willett B.J.
        • et al.
        Immunophenotypic characterization of feline Langerhans cells.
        Vet Immunol Immunopathol. 1997; 58: 1-16
        • Schjaerff M.
        • Keller S.M.
        • Fass J.
        • et al.
        Refinement of the canine CD1 locus topology and investigation of antibody binding to recombinant canine CD1 isoforms.
        Immunogenetics. 2016; 68: 191-204
        • Woo J.C.
        • Moore P.F.
        A feline homologue of CD1 is defined using a feline-specific monoclonal antibody.
        Tissue Antigens. 1997; 49: 244-251
        • Banchereau J.
        • Steinman R.M.
        Dendritic cells and the control of immunity.
        Nature. 1998; 392: 245-252
        • Scalapino K.J.
        • Daikh D.I.
        CTLA-4: a key regulatory point in the control of autoimmune disease.
        Immunol Rev. 2008; 223: 143-155
        • Buchbinder E.I.
        • Desai A.
        CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition.
        Am J Clin Oncol. 2016; 39: 98-106
        • Liang S.C.
        • Latchman Y.E.
        • Buhlmann J.E.
        • et al.
        Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.
        Eur J Immunol. 2003; 33: 2706-2716
        • Danilenko D.M.
        • Moore P.F.
        • Rossitto P.V.
        Canine leukocyte cell adhesion molecules (LeuCAMS): characterization of the CD11/CD18 family.
        Tissue Antigens. 1992; 40: 13-21
        • Danilenko D.M.
        • Rossitto P.V.
        • Van der Vieren M.
        • et al.
        A novel canine leukointegrin, alpha d beta 2, is expressed by specific macrophage subpopulations in tissue and a minor CD8+ lymphocyte subpopulation in peripheral blood.
        J Immunol. 1995; 155: 35-44
        • Van der Vieren M.
        • Crowe D.T.
        • Hoekstra D.
        • et al.
        The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1.
        J Immunol. 1999; 163: 1984-1990
        • Ide T.
        • Uchida K.
        • Kagawa Y.
        • et al.
        Pathological and immunohistochemical features of subdural histiocytic sarcomas in 15 dogs.
        J Vet Diagn Invest. 2011; 23: 127-132
        • Pierezan F.
        • Mansell J.
        • Ambrus A.
        • et al.
        Immunohistochemical expression of ionized calcium binding adapter molecule 1 in cutaneous histiocytic proliferative, neoplastic and inflammatory disorders of dogs and cats.
        J Comp Pathol. 2014; 151: 347-351
        • Kato Y.
        • Murakami M.
        • Hoshino Y.
        • et al.
        The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma.
        J Comp Pathol. 2013; 148: 188-196
        • Tomokiyo R.
        • Jinnouchi K.
        • Honda M.
        • et al.
        Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors.
        Atherosclerosis. 2002; 161: 123-132
        • Becker M.
        • Cotena A.
        • Gordon S.
        • et al.
        Expression of the class A macrophage scavenger receptor on specific subpopulations of murine dendritic cells limits their endotoxin response.
        Eur J Immunol. 2006; 36: 950-960
        • Marquet F.
        • Bonneau M.
        • Pascale F.
        • et al.
        Characterization of dendritic cells subpopulations in skin and afferent lymph in the swine model.
        PloS One. 2011; 6e16320
        • Yi H.
        • Guo C.
        • Yu X.
        • et al.
        Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.
        Cancer Res. 2011; 71: 6611-6620
        • Moore P.F.
        Systemic histiocytosis of Bernese mountain dogs.
        Vet Pathol. 1984; 21: 554-563
        • Moore P.F.
        • Rosin A.
        Malignant histiocytosis of Bernese mountain dogs.
        Vet Pathol. 1986; 23: 1-10
        • Mays M.B.
        • Bergeron J.A.
        Cutaneous histiocytosis in dogs.
        J Am Vet Med Assoc. 1986; 188: 377-381
        • Affolter V.K.
        • Moore P.F.
        Canine cutaneous and systemic histiocytosis: reactive histiocytosis of dermal dendritic cells.
        Am J Dermatopathol. 2000; 22: 40-48
        • Larregina A.T.
        • Morelli A.E.
        • Spencer L.A.
        • et al.
        Dermal-resident CD14+ cells differentiate into Langerhans cells.
        Nat Immunol. 2001; 2: 1151-1158
        • Moore P.F.
        Histiocytic Proliferative Diseases.
        in: Weiss D.J. Wardrop K.J. Schalm's Veterinary Hematology. 6 th edition. Wiley-Blackwell, 2010: 540-549 (chap 73)
        • Palmeiro B.S.
        • Morris D.O.
        • Goldschmidt M.H.
        • et al.
        Cutaneous reactive histiocytosis in dogs: a retrospective evaluation of 32 cases.
        Vet Dermatol. 2007; 18: 332-340
        • Moore P.F.
        • Affolter V.K.
        • Keller S.M.
        Canine inflamed nonepitheliotropic cutaneous T-cell lymphoma: a diagnostic conundrum.
        Vet Dermatol. 2013; 24: 204-211
        • Keller S.M.
        • Moore P.F.
        A novel clonality assay for the assessment of canine T cell proliferations.
        Vet Immunol Immunopathol. 2012; 145: 410-419
        • Affolter V.K.
        • Moore P.F.
        Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs.
        Vet Pathol. 2002; 39: 74-83
        • Taylor D.O.
        • Dorn C.R.
        • Luis O.H.
        Morphologic and biologic characteristics of the canine cutaneous histiocytoma.
        Cancer Res. 1969; 29: 83-92
        • Mulligan R.M.
        Neoplastic diseases of dogs. II. Mast cell sarcoma, lymphosarcoma, histiocytoma.
        Arch Path. 1948; 54: 147-166
        • Affolter V.
        • Moore P.F.
        Canine cutaneous histiocytic disease.
        in: Bonagura J.D. Current Veterinary therapy XIII: small Animal Practice. W.B. Saunders, 2000: 588-591
        • Faller M.
        • Lamm C.
        • Affolter V.K.
        • et al.
        Retrospective characterisation of solitary cutaneous histiocytoma with lymph node metastasis in eight dogs.
        J Small Anim Pract. 2016; 57: 548-552
        • Cockerell G.L.
        • Slauson D.O.
        Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma.
        J Comp Pathol. 1979; 89: 193-203
        • Baines S.J.
        • Blacklaws B.A.
        • McInnes E.
        • et al.
        CCH cells are potent stimulators in the allogeneic mixed leucocyte reaction.
        Vet Immunol Immunopathol. 2007; 119: 316-321
        • Glick A.D.
        • Holscher M.
        • Campbell G.R.
        Canine cutaneous histiocytoma: ultrastructural and cytochemical observations.
        Vet Pathol. 1976; 13: 374-380
        • Kelly D.F.
        Canine cutaneous histiocytoma. A light and electron microscopic study.
        Pathol Vet. 1970; 7: 12-27
        • Marchal T.
        • Dezutter-Dambuyant C.
        • Fournel C.
        • et al.
        Immunophenotypic and ultrastructural evidence of the Langerhans cell origin of the canine cutaneous histiocytoma.
        Acta Anat (Basel). 1995; 153: 189-202
        • Nfon C.K.
        • Dawson H.
        • Toka F.N.
        • et al.
        Langerhans cells in porcine skin.
        Vet Immunol Immunopathol. 2008; 126: 236-247
        • Ramos-Vara J.A.
        • Miller M.A.
        Immunohistochemical expression of E-cadherin does not distinguish canine cutaneous histiocytoma from other canine round cell tumors.
        Vet Pathol. 2011; 48: 758-763
        • Bender W.M.
        • Muller G.H.
        Multiple, resolving, cutaneous histiocytoma in a dog.
        J Am Vet Med Assoc. 1989; 194: 535-537
        • Frye F.L.
        • Carney J.
        • Cucuel J.P.
        Generalized eruptive histiocytoma in a dog.
        J Am Vet Med Assoc. 1969; 155: 1465-1466
        • Garma-Avina A.
        • Fromer E.
        Generalized cutaneous histiocytoma in a dog (a case report).
        Vet Med Small Anim Clin. 1979; 74: 1269-1270
        • Howard E.B.
        Eruptive histiocytoma in a dog.
        J Am Vet Med Assoc. 1970; 156: 140
        • Nagata M.
        • Hirata M.
        • Ishida T.
        • et al.
        Progressive Langerhans' cell histiocytosis in a puppy.
        Vet Dermatol. 2000; 11: 241-246
        • Munn S.
        • Chu A.C.
        Langerhans cell histiocytosis of the skin.
        Hematol Oncol Clin North Am. 1998; 12: 269-286
        • Schmitz L.
        • Favara B.E.
        Nosology and pathology of Langerhans cell histiocytosis.
        Hematol Oncol Clin North Am. 1998; 12: 221-246
        • Court E.A.
        • Earnest-Koons K.A.
        • Barr S.C.
        • et al.
        Malignant histiocytosis in a cat.
        J Am Vet Med Assoc. 1993; 203: 1300-1302
        • Freeman L.
        • Stevens J.
        • Loughman C.
        • et al.
        Clinical vignette. Malignant histiocytosis in a cat.
        J Vet Intern. 1995; 9: 171-173
        • Friedrichs K.R.
        • Young K.M.
        Histiocytic sarcoma of macrophage origin in a cat: case report with a literature review of feline histiocytic malignancies and comparison with canine hemophagocytic histiocytic sarcoma.
        Vet Clin Pathol. 2008; 37: 121-128
        • Kraje A.C.
        • Patton C.S.
        • Edwards D.F.
        Malignant histiocytosis in 3 cats.
        J Vet Intern Med. 2001; 15: 252-256
        • Pinard J.
        • Wagg C.R.
        • Girard C.
        • et al.
        Histiocytic sarcoma in the tarsus of a cat.
        Vet Pathol. 2006; 43: 1014-1017
        • Padgett G.A.
        • Madewell B.R.
        • Keller E.T.
        • et al.
        Inheritance of histiocytosis in Bernese mountain dogs.
        J Small Anim Pract. 1995; 36: 93-98
        • Abadie J.
        • Hedan B.
        • Cadieu E.
        • et al.
        Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed.
        J Hered. 2009; 100: S19-S27
        • Constantino-Casas F.
        • Mayhew D.
        • Hoather T.M.
        • et al.
        The clinical presentation and histopathologic-immunohistochemical classification of histiocytic sarcomas in the Flat Coated Retriever.
        Vet Pathol. 2011; 48: 764-771
        • Kagawa Y.
        • Nakano Y.
        • Kobayashi T.
        • et al.
        Localized pulmonary histiocytic sarcomas in Pembroke Welsh Corgi.
        J Vet Med Sci. 2016; 77: 1659-1661
        • Thongtharb A.
        • Uchida K.
        • Chambers J.K.
        • et al.
        Histological and immunohistochemical studies on primary intracranial canine histiocytic sarcomas.
        J Vet Med Sci. 2016; 78: 593-599
        • Hedan B.
        • Thomas R.
        • Motsinger-Reif A.
        • et al.
        Molecular cytogenetic characterization of canine histiocytic sarcoma: a spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.
        BMC Cancer. 2011; 11: 201
        • Shearin A.L.
        • Hedan B.
        • Cadieu E.
        • et al.
        The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancer.
        Cancer Epidemiol biomarkers Prev. 2012; 21: 1019-1027
        • Takada M.
        • Hix J.M.L.
        • Corner S.
        • et al.
        Targeting MEK in a translational model of histiocytic sarcoma.
        Mol Cancer Ther. 2018; 17: 2439-2450
        • Thaiwong T.
        • Sirivisoot S.
        • Takada M.
        • et al.
        Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs. Veterinary and comparative oncology.
        Jun. 2018; 16: 220-228
        • Moore P.F.
        • Affolter V.K.
        • Vernau W.
        Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages.
        Vet Pathol. 2006; 43: 632-645
        • Skorupski K.A.
        • Clifford C.A.
        • Paoloni M.C.
        • et al.
        CCNU for the treatment of dogs with histiocytic sarcoma.
        J Vet Intern Med. 2007; 21: 121-126
        • Allison R.W.
        • Brunker J.D.
        • Breshears M.A.
        • et al.
        Dendritic cell leukemia in a Golden Retriever.
        Vet Clin Pathol. 2008; 37: 190-197
        • Rossi S.
        • Gelain M.E.
        • Comazzi S.
        Disseminated histiocytic sarcoma with peripheral blood involvement in a Bernese Mountain dog. Case Reports.
        Vet Clin Pathol. 2009; 38: 126-130
        • Craig L.E.
        • Julian M.E.
        • Ferracone J.D.
        The diagnosis and prognosis of synovial tumors in dogs: 35 cases.
        Vet Pathol. 2002; 39: 66-73
        • van Kuijk L.
        • van Ginkel K.
        • de Vos J.P.
        • et al.
        Peri-articular histiocytic sarcoma and previous joint disease in Bernese Mountain Dogs.
        J Vet Intern Med. 2013; 27: 293-299
        • Skorupski K.A.
        • Rodriguez C.O.
        • Krick E.L.
        • et al.
        Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as an adjuvant to local therapy.
        Vet Comp Oncol. 2009; 7: 139-144
        • Cannon C.
        • Borgatti A.
        • Henson M.
        • et al.
        Evaluation of a combination chemotherapy protocol including lomustine and doxorubicin in canine histiocytic sarcoma.
        J Small Anim Pract. 2015; 56: 425-429
        • Choi J.W.
        • Withers S.S.
        • Chang H.
        • et al.
        Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function.
        PloS One. 2020; 15: e0235518
        • Haran K.P.
        • Lockhart A.
        • Xiong A.
        • et al.
        Generation and validation of an antibody to canine CD19 for diagnostic and future therapeutic purposes.
        Vet Pathol. 2020; 57: 241-252
        • Panjwani M.K.
        • Atherton M.J.
        • MaloneyHuss M.A.
        • et al.
        Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma.
        Oncoimmunology. 2020; 9: 1676615
        • Affolter V.K.
        • Moore P.F.
        Feline progressive histiocytosis.
        Vet Pathol. 2006; 43: 646-655
        • Treggiari E.
        • Ressel L.
        • Polton G.A.
        • et al.
        Clinical outcome, PDGFRbeta and KIT expression in feline histiocytic disorders: a multicentre study. Veterinary and comparative oncology.
        Mar. 2017; 15: 65-77
        • Korenfeld D.
        • Gorvel L.
        • Munk A.
        • et al.
        A type of human skin dendritic cell marked by CD5 is associated with the development of inflammatory skin disease.
        JCI Insight. 2017; 2: e96101
        • Busch M.D.
        • Reilly C.M.
        • Luff J.A.
        • et al.
        Feline pulmonary Langerhans cell histiocytosis with multiorgan involvement.
        Vet Pathol. 2008; 45: 816-824
        • Argenta F.F.
        • de Britto F.C.
        • Pereira P.R.
        • et al.
        Pulmonary Langerhans cell histiocytosis in cats and a literature review of feline histiocytic diseases.
        J feline Med Surg. 2020; 22: 305-312
        • Yousem S.A.
        • Colby T.V.
        • Chen Y.Y.
        • et al.
        Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality.
        Am J Surg Pathol. 2001; 25: 630-636